Niagen Bioscience Inc (NAGE) Q3 2026 Earnings Call Highlights: Cash Flow Positive Despite Sales ...
Niagen Bioscience Inc (NAGE) posted $2.6 million in operating cash flow and a $69.5 million cash position even as net sales fell 10% to $27.2 million and gross margin slipped to 62.9%. Related Stocks: NAGE ,